Titan Pharmaceuticals Inc TTNP Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	8.32M	6.28M	4.06M	2.17M	812k	10M	8.09M	6.65M
Total Current Assets	7.71M	5.75M	3.6M	1.79M	498k	9.9M	8.02M	6.61M
Cash and Equivalents	6.42M	4.45M	2.94M	1.14M	105k	8.1M	6.76M	6.16M
Total Non-Current Assets	606k	529k	679k	383k	314k	100k	73k	35k
Total Liabilities	2.65M	2.73M	2.7M	2.48M	1.85M	1.87M	1.44M	559k
Total Current Liabilities	2.52M	2.63M	2.63M	2.45M	1.85M	1.87M	1.44M	559k
Total Non-Current Liabilities	128k	96k	65k	33k	0	0	0	0
Common Equity	15k	15k	15k	15k	15k	16k	2k	2k
Retained Earnings	-381.06M	-383.7M	-386.26M	-387.94M	-389.52M	-389.86M	-391.83M	-392.89M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	18.67M	8.91M	14.1M	9.52M	8.09M	7.99M	4.06M	8.09M
Total Current Assets	17.83M	8.31M	13.3M	8.31M	7.33M	7.23M	3.6M	8.02M
Cash and Equivalents	14.01M	7.52M	9.3M	5.22M	5.41M	6.04M	2.94M	6.76M
Total Non-Current Assets	13.19M	857k	6.83M	1.43M	3.53M	5.14M	1.36M	6.64M
Total Liabilities	5.48M	8.05M	7.26M	8.09M	4.56M	2.86M	2.7M	1.44M
Total Current Liabilities	4.86M	4.46M	3.45M	3.6M	4.22M	2.67M	2.63M	1.44M
Total Non-Current Liabilities	619k	7.17M	7.6M	8.51M	664k	187k	65k	0
Total Equity	13.19M	857k	6.83M	1.43M	3.53M	5.14M	1.36M	6.64M
Common Equity	297.86M	297.86M	13k	57k	7k	10k	15k	2k
Retained Earnings	-308.96M	-323.27M	-332.58M	-349.04M	-367.28M	-376.06M	-386.26M	-391.83M